The choice depends on the goal (sleep quality, recovery, body composition, general growth hormone support), the patients response, tolerance for dosing frequency, and side effect considerations
Clinical trials found that people who took semaglutide lost an average of 10% more body weight than those who were given a placebo over one year of treatment
Novo Nordisks semaglutide (Ozempic for diabetes, Wegovy for obesity) and Eli Lillys dual-agonist tirzepatide (Mounjaro, a related drug that also activates the GIP hormone receptor) have become blockbusters , propelling their companies to record-high market valuations ( [15] ) ( [16] )
demonstrated that GLS-2 reduces cellular sensitivity to ROS-related apoptosis [19]
You can start seeing results from fat dissolving injections after 2 to 4 weeks, as the body gradually breaks down and eliminates the fat cells, with improvements continuing over time
Others didn't truly stop obesity treatment at all: More than one-quarter switched to a different weight loss medication, and nearly one in five restarted their original GLP-1 within about six months
